Korean Biopharma Beefs Up Open Innovation to Raise Pipelines’ Value
The Korea Biomedical Review reported that Korean pharmaceutical and biotech companies are using various open innovation tools to raise competitiveness in new drug development in the global market. In the past, Korean drugmakers conducted research in secrecy due to the risk of technology leakage. But now, they actively get technologies and business
Comments Off on Korean Biopharma Beefs Up Open Innovation to Raise Pipelines’ Value • Read this story »
More Articles
Open innovation: A Paradigm Shift in Pharma R&D?
The Science Direct website reported that Open innovation (OI) holds promise to accelerate, diversify, and innovate research and development (R&D) in the pharmaceutical industry. It remains to be assessed in which way and to what extent OI is leveraged in practice by current pharmaceutical R&D
Comments Off on Open innovation: A Paradigm Shift in Pharma R&D? • Read this story »
How to Tackle Innovation in Pharma Head On
The Pharmaceutical Manufacturer website reported that the pharma industry is pushing forward on product innovation faster than ever before. The development of new, innovative drug formulations implies a new challenge for the supply chain, in particular pharma packaging manufacturers. To keep up the pace
Comments Off on How to Tackle Innovation in Pharma Head On • Read this story »
Applying Open Innovation Strategies in Regional Innovation Ecosystems
The Science Direct site posted a study which noted that open innovation strategies in large firms have been changing considerably during the last 15 years. Some multinationals are now taking a long-term, strategic approach to open innovation, thereby actively developing a regionally bounded innovation
Comments Off on Applying Open Innovation Strategies in Regional Innovation Ecosystems • Read this story »
A Joint Front: Open Source Pharma
An article on the Business Today (India) website noted that an open source drug discovery program allows capabilities to be linked and used, at negligible cost. India has already taken a step in this direction. Bill Gates, who built his empire on proprietary software, tweeted that open innovation
Comments Off on A Joint Front: Open Source Pharma • Read this story »
Open Innovation and External Sources of Innovation.
The Journal of Translational Medicine noted that historically, research and development (R&D) in the pharmaceutical sector has predominantly been an in-house activity. In recent years, multiple extrinsic and intrinsic factors induced an opening for external sources of innovation and resulted in
Comments Off on Open Innovation and External Sources of Innovation. • Read this story »